Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 4.05 USD 2.79%
Updated: Jun 3, 2024

Design Therapeutics Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Design Therapeutics Inc
Additional Paid In Capital Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Additional Paid In Capital
$455.2m
CAGR 3-Years
869%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Additional Paid In Capital
$20.7B
CAGR 3-Years
5%
CAGR 5-Years
7%
CAGR 10-Years
18%
Gilead Sciences Inc
NASDAQ:GILD
Additional Paid In Capital
$6.8B
CAGR 3-Years
19%
CAGR 5-Years
22%
CAGR 10-Years
2%
Amgen Inc
NASDAQ:AMGN
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Additional Paid In Capital
$7.3B
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Additional Paid In Capital
$11.9B
CAGR 3-Years
20%
CAGR 5-Years
23%
CAGR 10-Years
18%

See Also

What is Design Therapeutics Inc's Additional Paid In Capital?
Additional Paid In Capital
455.2m USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Additional Paid In Capital amounts to 455.2m USD.

What is Design Therapeutics Inc's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 3Y
869%

Over the last year, the Additional Paid In Capital growth was 3%. The average annual Additional Paid In Capital growth rates for Design Therapeutics Inc have been 869% over the past three years .